Type 2 diabetes and obesity dramatically increase the risk of dementia by up to 60%, accelerating amyloid pathology, cerebrovascular damage, and insulin resistance in the brain, sometimes described as type 3 diabetes [1]
Clinical Evidence and Scientific Studies A landmark 2023 study published in the Journal of the American Medical Association revealed alarming statistics about the gastrointestinal risks associated with GLP-1 receptor agonists like Ozempic, particularly when used for weight loss purposes
It does not diagnose symptoms, tell you whether a side effect is dangerous, or recommend dose changes
May your serums stay stable, your skin stay supple, and your copper peptides stay potent
If You Hit a Plateau If your weight hasnt changed in the direction you want for about two weeks, you've likely hit a plateau
A Qualitative Synthesis and Systematic Review Analysis of Studies on palatable food, drugs of abuse, and Alcohol